Literature DB >> 6679152

Inhibition of the growth of Ureaplasma urealyticum by a new urease inhibitor, flurofamide.

G E Kenny.   

Abstract

Flurofamide (N-[diaminophosphinyl]-4-fluorobenzamide), a urease inhibitor, was a potent inhibitor of the growth of Ureaplasma urealyticum. As little as 10 microM flurofamide (2 micrograms/ml) prevented any growth, but U. urealyticum survived for about eight hours before colony counts become undetectable. Flurofamide was a specific inhibitor of U. urealyticum since it did not inhibit growth of four Mycoplasma species or Acholeplasma hippikon. Flurofamide was 1,000 times more active than acetohydroxamic acid and thus has promise as a chemotherapeutic agent and a biochemical tool.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6679152      PMCID: PMC2590538     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  6 in total

1.  Multiple forms of urease in cytoplasmic fractions of Ureaplasma urealyticum.

Authors:  G J Delisle
Journal:  J Bacteriol       Date:  1977-06       Impact factor: 3.490

2.  Flurofamide: a potent inhibitor of bacterial urease with potential clinical utility in the treatment of infection induced urinary stones.

Authors:  O E Millner; J A Andersen; M E Appler; C E Benjamin; J G Edwards; D T Humphrey; E M Shearer
Journal:  J Urol       Date:  1982-02       Impact factor: 7.450

3.  Effect of urea concentration on growth of Ureaplasma urealyticum (T-strain mycoplasma).

Authors:  G E Kenny; F D Cartwright
Journal:  J Bacteriol       Date:  1977-10       Impact factor: 3.490

4.  Growth of T-strain mycoplasmas in medium without added urea: effect of trace amounts of urea and of a urease inhibitor.

Authors:  G K Masover; J R Benson; L Hayflick
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

5.  Growth and effects of ureaplasmas (T mycoplasmas) in bovine oviductal organ cultures.

Authors:  O H Stalheim; S J Proctor; J E Gallagher
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

6.  Adenosine 5'-triphosphate synthesis induced by urea hydrolysis in Ureaplasma urealyticum.

Authors:  N Romano; G Tolone; F Ajello; R La Licata
Journal:  J Bacteriol       Date:  1980-11       Impact factor: 3.490

  6 in total
  8 in total

Review 1.  Microbial ureases: significance, regulation, and molecular characterization.

Authors:  H L Mobley; R P Hausinger
Journal:  Microbiol Rev       Date:  1989-03

2.  Characteristics of Ureaplasma urealyticum urease.

Authors:  A Blanchard; S Razin; G E Kenny; M F Barile
Journal:  J Bacteriol       Date:  1988-06       Impact factor: 3.490

3.  Hydrolysis of urea by Ureaplasma urealyticum generates a transmembrane potential with resultant ATP synthesis.

Authors:  D G Smith; W C Russell; W J Ingledew; D Thirkell
Journal:  J Bacteriol       Date:  1993-06       Impact factor: 3.490

4.  Screening of an antigen target for immunocontraceptives from cross-reactive antigens between human sperm and Ureaplasma urealyticum.

Authors:  Jianli Shi; Zhengmin Yang; Min Wang; Guoyan Cheng; Ding Li; Yifei Wang; Yuancong Zhou; Xiaolong Liu; Chen Xu
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

5.  S.E.M. study of urease-induced crystalluria in the presence of hydroxamic derivatives.

Authors:  M Ben Amar; G L'Espérance; R Tawashi
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

6.  The failure of flurofamide to control ureaplasma in bovine semen.

Authors:  R B Truscott; C Brown
Journal:  Can J Vet Res       Date:  1986-04       Impact factor: 1.310

7.  Virulence of ureaplasmal urease for mice.

Authors:  J V Ligon; G E Kenny
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

8.  Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum.

Authors:  K Nagata; E Takagi; H Satoh; H Okamura; T Tamura
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.